Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Abstract Tremendous progress has been made to control the COVID‐19 pandemic caused by the SARS‐CoV‐2 virus. However, effective therapeutic options are still rare. Drug repurposing and combination represent practical strategies to address this urgent unmet medical need. Viruses, including coronavirus...

Full description

Bibliographic Details
Main Authors: Kuoyuan Cheng, Laura Martin‐Sancho, Lipika R Pal, Yuan Pu, Laura Riva, Xin Yin, Sanju Sinha, Nishanth Ulhas Nair, Sumit K Chanda, Eytan Ruppin
Format: Article
Language:English
Published: Springer Nature 2021-10-01
Series:Molecular Systems Biology
Subjects:
antiviral target
genome‐scale metabolic modeling
remdesivir
RNAi screen
SARS‐CoV‐2
Online Access:https://doi.org/10.15252/msb.202110260

Internet

https://doi.org/10.15252/msb.202110260

Similar Items